State Attorneys General (AGs) play a central role in enforcing cannabis laws and protecting consumers. As legalization continues to sweep the country, the interplay between state and federal law demands particular attention. In this edition of The 411 on 420,
Continue Reading The Role of State AGs in Cannabis Policy and Regulation: A Conversation with Austin Bernstein
To say that the United States has a complicated relationship with hemp is an understatement. In this edition of The 411 on 420, Perkins Coie partner Barak Cohen discusses hemp’s complicated past and promising future with Eric Steenstra, founding member
Continue Reading Delta 8, CBD, 1% THC, and Other Issues Affecting the Hemp Industry: A Conversation with Eric Steenstra
Late last evening, the U.S. House of Representatives passed SAFE Banking legislation by voice vote, offered as an amendment to the National Defense Authorization Act (NDAA/H.R. 4350). While SAFE Banking legislation previously passed in the House, it had stalled in
Continue Reading U.S. House Votes SAFE Banking Legislation into Defense Bill
Earlier this month, California legislators passed a law, AB 45, aimed at providing guardrails for an expanded consumer marketplace for products containing hemp and hemp-derived cannabidiol (CBD) in California. Given that the bill will take effect immediately following Governor
Continue Reading Five Takeaways From California’s New State Industrial Hemp Bill
In this edition of The 411 on 420, Perkins Coie partner Megan Morrissey was joined by Nancy Whiteman (CEO of Wana Brands), Gail Rand (CEO and Founder of grand consulting), and Allison Pugina (Category Manager of Canopy Growth Corporation) to
Continue Reading Actionable Insights for Winning Product Development and Branding Strategies
Millions of Americans are utilizing medical cannabis and psilocybin to treat specific medical conditions each day. However, scientific and medical research lags in the U.S. lags behind other nations. Dr. Stephen M. Dahmer, Chief Medical Officer at Vireo Health, and
Continue Reading The Future of Cannabis and Psilocybin as Plant-Based Medicine: A Conversation with Stephen Dahmer and Betty Aldworth
While most people are discussing federal legalization of cannabis these days, the industry operates at a local level and the role of state-level cannabis associations is crucial. Perkins Coie associate Michael Bleicher is joined by Truman Bradley, Executive Director of
Continue Reading The Role of State-Level Cannabis Associations: A Conversation with Truman Bradley
Last week, Senators Schumer (D-NY), Booker (D-NJ), and Wyden (D-OR) circulated a discussion draft of the Cannabis Administration and Opportunity Act, a legislative proposal to deschedule and legalize cannabis. In related statements to the Senate, Senator Schumer emphasized that
Continue Reading Senators Propose Cannabis Descheduling Plan: Five Takeaways for The Cannabis Industry
The third version of the Marijuana Opportunity Reinvestment and Expungement, or MORE, Act was introduced on May 28. Perkins Coie lawyers Barak Cohen and Andrew Kline, in partnership with Yoko Miyashita, CEO of Leafly, authored an article discussing
Continue Reading Federal Cannabis Descheduling Bill Needs More Clarity
As cannabis is legalized on a state-by-state basis, individual states are creating their own cannabis testing requirements to ensure consumer safety, and many of these requirements differ from one state to the next. Perkins Coie associate Michael Bleicher is joined
Continue Reading Cannabis Lab Testing and Standards Post Descheduling: A Conversation with Alena Rodriguez
